Schistosomiasis
Section snippets
The parasites
Adult schistosomes are macroscopically visible worms, with a white-grayish, cylindrical body approximately 1 to 1.5 cm in length.1, 2, 3 Taxonomically, they belong to the class of Trematoda (flukes) and the phylum of Platyhelminthes (flatworms). The worms live in the bloodstream of the human host, where they can survive for up to 30 years with an average of 3 to 5 years. This is a remarkable evolutionary achievement, which requires intricate evasion mechanisms to all forms of innate and
Transmission
The transmission cycle of schistosomes is shown in Fig. 2. The female worms produce hundreds (Schistosoma mansoni and S haematobium) to thousands (S japonicum) of eggs per day, which are 100 to 180 μm in size and have a typical shape and spine that varies per species. Each egg contains one ciliated larva, the miracidium, which secretes enzymes that help the eggs to migrate from the blood vessels through the tissues into the lumen of the bladder (S haematobium) or the intestine (S mansoni and S
Distribution and epidemiology
Humans are host to six Schistosoma species, which are morphologically very similar. Their distribution is primarily determined by the presence of the intermediate hosts. The different location of the species in the human body leads not only to a different excretion path, but also to different pathology. Three species are of global or regional importance (Fig. 3): S japonicum (China and Southeast Asia) and S mansoni (Africa, Arabia, and South America) dwell in peri-intestinal venula, and cause
Acute pathology
Minutes after the cercarial infection, local urticaria may appear that usually last for a few hours but sometimes persist for days as more papulous lesions (Fig. 4). This “swimmers itch” is mainly seen after primary infections, especially in tourists and migrants. A similar syndrome can also be caused by animal trematodes in temperate climate zones, including North America and Europe.
One to four weeks after infection, the migrating and maturing schistosomula can cause a systemic
Chronic pathology
Particularly in local populations, the main morbidity is caused by years of chronic infection in which not the worms but the eggs are the culprit.1, 2, 3, 15 As described, during their migration most eggs are trapped in tissues surrounding the intestinal or urinary systems, or in the liver and spleen after being evacuated by the bloodstream. The enzymes excreted to assist their penetration cause subsequently inflammatory and granulomatous immune reactions, characterized by eosinophilic
Diagnosis
The gold standard for the diagnosis of Schistosoma infection is the microscopic detection of eggs in stools or urine.1, 2, 3, 24 The typical size and shape allow an easy distinction from other helminth eggs, and among schistosome species (Fig. 9). Concentration methods and examination of several specimens may be needed to detect light infections.25 For epidemiologic purposes, the eggs can be counted in a fixed amount of urine or feces, allowing an estimation of intensity of infection.1, 2, 3
Treatment
Until the 1970s, the treatment of schistosomiasis was almost as difficult and toxic as it still is today for trypanosomiasis and leishmaniasis.10, 33 Because pathology was limited in many cases, the decision to treat or not could be a real dilemma and wide-scale application for control purposes was a hazardous undertaking. In the early 1980s, praziquantel, an acylated quinoline–pyrazine active against all schistosome species in a single oral dose, came on the market.33 It paralyzes and kills
Control
The control and prevention of schistosomiasis used to be largely based on the chemical destruction or environmental management of snail populations, a difficult, costly, and mostly inefficient method (Fig. 10).1, 3, 10 Some countries, most notably Japan in the 1950s, have nevertheless been able to eliminate schistosomiasis by combining this approach with water supply, sanitation, and environmental interventions.38 Nowadays, the emphasis has entirely shifted to preventive chemotherapy of
References (43)
- et al.
Human schistosomiasis
(1993) - et al.
Schistosomiasis
N Engl J Med
(2002) - et al.
Human schistosomiasis
Lancet
(2006) - et al.
Global distribution of schistosomiasis: CEGET/WHO Atlas
World Health Stat Q
(1984) Freshwater snails of Africa and their medical importance
(1994)- et al.
Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century
Clin Microbiol Rev
(2001) - et al.
The global status of schistosomiasis and its control
Acta Trop
(2000) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee
World Health Organ Tech Rep Ser
(2002)Global burden of disease: update 2004
(2008)From Katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia
Acta Trop
(2000)
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
Lancet Infect Dis
Schistosomiasis in travelers and expatriates
J Travel Med
Katayama syndrome
Lancet Infect Dis
Schistosomiasis in travellers and migrants
Travel Med Infect Dis
Immunopathology of schistosomiasis
Immunol Cell Biol
Regauging the cost of chronic helminthic infection: meta-analysis of disability-related outcomes in endemic schistosomiasis
Lancet
Helminths and malignancy
Parasite Immunol
Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors
Hepatology
Pulmonary schistosomiasis
Clin Chest Med
The changing face of schistosomal glomerulopathy
Kidney Int
Report of an informal working group meeting on urogenital schistosomiasis and HIV transmission
Cited by (250)
SjHSP90 recombinant protein and its possible application in the diagnosis of schistosomiasis and treatment efficacy monitoring
2023, Acta TropicaCitation Excerpt :In China, schistosomiasis is prevalent in 450 counties (cities or districts) and 28,500 villages, affecting 70,667,800 people (Zhang et al., 2020). Rapid and accurate diagnosis is the key to all aspects of schistosomiasis control (Gryseels, 2012; Gray et al., 2011; Ross et al., 2012; Colley et al., 2014). Timely identifying patients and determining treatment effects will protect the labor force, control the source of infection, and prevent the spread of diseases.
Antischistosomal tetrahydro-γ-carboline sulfonamides
2022, Bioorganic and Medicinal Chemistry Letters